Physician profile
Praneeth Bandaru
NPI 1366937989
$8,692.85
in general payments reported to CMS, 2019-2025
12 companies · $5,139 in 2025
The $5,139 reported for 2025 was more than what 91% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $75.00 · 2024: $3,479 · 2025: $5,139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,581 · Food and Beverage: $3,083 · Education: $28.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,580.89 |
| Food and Beverage | $3,083.14 |
| Education | $28.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,550.57 | 2024-2025 | Axios, Overstitch Endoscopic Suturing System, Exalt Model D |
| Olympus Corporation of The Americas | $2,525.80 | 2025 | Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655, Olympus |
| Ovesco Endoscopy USA, INC. | $322.81 | 2025 | |
| Abbvie INC. | $313.73 | 2024-2025 | |
| Gilead Sciences, INC. | $237.14 | 2024 | Vemlidy |
| Olympus America INC. | $209.22 | 2025 | Visiglide, Single Use Electrosurgical Knife Kd-655, Single Use Repositionable Clip |
| Fujifilm Healthcare Americas Corporation | $160.00 | 2023-2024 | |
| Madrigal Pharmaceuticals | $144.99 | 2025 | Rezdiffra |
| Janssen Biotech, INC. | $144.12 | 2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $29.82 | 2024 | Eohilia |
| Celltrion USA INC. | $28.82 | 2024 | Zymfentra |
| Celgene Corporation | $25.83 | 2024 | Zeposia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Praneeth Bandaru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.